Wegovy HD—offering the highest weight-loss of any Wegovy injection so far—is now available nationwide, the compay said.

Novo got approval for the higher dose of its Wegovy injection in March based on results from a late-stage clinical trial in which 89% of participants taking the higher dose achieved 5% or greater ...

Novo Nordisk says people will save up to $1,200 per year on the Wegovy injection and $600 per year on the pill under the new ...

Americans starting weight-loss medicines for the first time want lower cost and greater convenience as they consider pills ...

Food does not affect Foundayo, so it can be taken with or without food. In contrast, oral Wegovy has to be taken on an empty ...

Novo Nordisk launched the high dose version of its GLP-1 injection at a price that’s $50 lower than the one for Eli Lilly’s ...

While the injectable retains convenience advantages in dosing frequency, the pill addresses needle aversion and may ...

Longer subscriptions offer lower monthly pricing, with people expected to save up to $1,200 a year on the injection and as ...

The FDA approves Wegovy HD (semaglutide 7.2 mg) for chronic weight management in adults with obesity or overweight and weight-related conditions.

The 7.2-milligram dose, branded as Wegovy HD, gained approval under the FDA Commissioner's National Priority Review Voucher ...

Drugmakers Novo Nordisk and Eli Lilly and Company have transformed the landscape of chronic weight loss management with the ...

Under the new priority voucher program (CNPV), the FDA has approved a new oral GLP-1 drug, Foundayo, offering an alternative ...